Comparison of Widefield OCT Angiography Features Between Severe Non-Proliferative and Proliferative Diabetic Retinopathy

被引:0
|
作者
Drira, Ines [1 ,2 ]
Noor, Maha [1 ]
Stone, Amy [1 ]
D'Souza, Yvonne [1 ]
John, Binu [1 ]
Mcgrath, Orlaith [1 ]
Patel, Praveen J. [3 ,4 ]
Aslam, Tariq [1 ]
机构
[1] Univ Manchester, Manchester Royal Eye Hosp, Oxford Rd, Manchester M13 9WL, Lancs, England
[2] Hosp Toulouse, Pl Du Dr Joseph Baylac, F-31300 Toulouse, France
[3] Natl Hlth Serv Fdn Trust, Moorfields Eye Hosp, Natl Inst Hlth & Care Res, Biomed Res Ctr, London, England
[4] UCL, Inst Ophthalmol, London, England
关键词
Proliferative diabetic retinopathy; Severe diabetic retinopathy; OCT-A; Image analysis; New vessels; Retinal ischemia; OCT-A metrics; Fluorescein angiography; COHERENCE TOMOGRAPHY ANGIOGRAPHY;
D O I
10.1007/s40123-024-00886-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
IntroductionThere is a high and ever-increasing global prevalence of diabetic retinopathy (DR) and invasive imaging techniques are often required to confirm the presence of proliferative disease. The aim of this study was to explore the images of a rapid and non-invasive technique, widefield optical coherence tomography angiography (OCT-A), to study differences between patients with severe non-proliferative and proliferative DR (PDR).MethodsWe conducted an observational longitudinal study from November 2022 to March 2023. We recruited 75 patients who were classified into a proliferative group (28 patients) and severe non-proliferative group (47 patients). Classification was done by specialist clinicians who had full access to any multimodal imaging they required to be confident of their diagnosis, including fluorescein angiography. For all patients, we performed single-shot 4 x 4 and 10 x 10 mm (widefield) OCT-A imaging and when possible, the multiple images required for mosaic 17.5 x 17.5 mm (ultra widefield) OCT-A imaging. We assessed the frequency with which proliferative disease was identifiable solely from these OCT-A images and used custom-built MATLAB software to analyze the images and determine computerized metrics such as density and intensity of vessels, foveal avascular zone, and ischemic areas.ResultsOn clinically assessing the OCT-A 10 x 10 fields, we were only able to detect new vessels in 25% of known proliferative images. Using ultra-widefield mosaic images, however, we were able to detect new vessels in 100% of PDR patients. The image analysis metrics of 4 x 4 and 10 x 10 mm images did not show any significant differences between the two clinical groups. For mosaics, however, there were significant differences in the capillary density in patients with PDR compared to severe non-PDR (9.1% +/- 1.9 in the PDR group versus 11.0% +/- 1.9 for severe group). We also found with mosaics a significant difference in the metrics of ischemic areas; average area of ischemic zones (253,930.1 +/- 108,636 for the proliferative group versus 149,104.2 +/- 55,101.8 for the severe group.ConclusionsOur study showed a high sensitivity for detecting PDR using only ultra-widefield mosaic OCT-A imaging, compared to multimodal including fluorescein angiography imaging. It also suggests that image analysis of aspects such as ischemia levels may be useful in identifying higher risk groups as a warning sign for future conversion to neovascularization.
引用
收藏
页码:819 / 830
页数:12
相关论文
共 50 条
  • [1] Comparison of Widefield OCT Angiography Features Between Severe Non-Proliferative and Proliferative Diabetic Retinopathy
    Ines Drira
    Maha Noor
    Amy Stone
    Yvonne D’Souza
    Binu John
    Orlaith McGrath
    Praveen J. Patel
    Tariq Aslam
    Ophthalmology and Therapy, 2024, 13 : 831 - 849
  • [2] Non-proliferative diabetic retinopathy
    Danek, Dagmara
    Larsen, Brian
    Anderson-Nelson, Susan
    DM DISEASE-A-MONTH, 2021, 67 (05):
  • [3] Conjunctival impression cytology in non-proliferative and proliferative diabetic retinopathy
    Citirik, Mehmet
    Berker, Nilufer
    Haksever, Hulya
    Elgin, Ufuk
    Ustun, Huseyin
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2014, 7 (02) : 321 - 325
  • [4] Retinal bifurcation angles in severe non-proliferative diabetic retinopathy
    Golestani, Shahin
    Banaee, Touka
    Daneshvar, Ramin
    Nabavi, Amin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [5] Conjunctival impression cytology in non-proliferative and proliferative diabetic retinopathy
    Mehmet Citirik
    Nilufer Berker
    Hulya Haksever
    Ufuk Elgin
    Huseyin Ustun
    International Journal of Ophthalmology, 2014, (02) : 321 - 325
  • [6] Oct biomarkers of treatment-naive diabetic macular edema in patients with non-proliferative and proliferative diabetic retinopathy
    Kumral, Esra Turkseven
    Ercalik, Nimet Yesim
    Alpogan, Oksan
    Yenerel, Nursal Melda
    Kose, Alev Ozcelik
    Ozturk, Yucel
    Acar, Zeynep Ayse
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2023, 33 (02) : 1061 - 1067
  • [7] Non-proliferative diabetic retinopathy - new findings in indocyanine green angiography
    Yassur, Y
    Weinberger, D
    Kremer, M
    Gaton, D
    Axer-Siegal, R
    Priel, ER
    RETINAL PIGMENT EPITHELIUM AND MACULAR DISEASES, 1998, 62 : 397 - 399
  • [8] Expanded Field OCT Angiography Biomarkers for Predicting Clinically Significant Outcomes in Non-Proliferative Diabetic Retinopathy
    Ding, Xinyi
    Romano, Francesco
    Garg, Itika
    Gan, Jenny
    Vingopoulos, Filippos
    Garcia, Mauricio d.
    Overbey, Katherine m.
    Cui, Ying
    Zhu, Ying
    Bennett, Cade f.
    Stettler, Isabella
    Shan, Mridula
    Finn, Matthew j.
    Vavvas, Demetrios g.
    Husain, Deeba
    Patel, Nimesh a.
    Kim, Leo a.
    Miller, John b.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2025, 270 : 216 - 226
  • [9] Pupillary responses in non-proliferative diabetic retinopathy
    Jason C. Park
    Yi-Fan Chen
    Norman P. Blair
    Felix Y. Chau
    Jennifer I. Lim
    Yannek I. Leiderman
    Mahnaz Shahidi
    J. Jason McAnany
    Scientific Reports, 7
  • [10] Automatic grading of non-proliferative diabetic retinopathy
    Suman S.
    Tiwari A.K.
    Singh K.
    Research on Biomedical Engineering, 2023, 39 (03) : 677 - 692